Row over SMA drug distribution in Keralam unwarranted, say experts
SAT Hospital authorities deny the claim of parents of SMA children that the drug given free of cost at the hospital clinic was an “experimental drug.” Hospital authorities say what was given was the generic version of Risdiplam, the patented original formula by Roche, now manufactured by the Indian firm Natco Pharma and which has been approved by drug regulatory bodies in the country
Read the full report on The Hindu
Story file
How this page works. The Headline Update lists this report from The Hindu with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.
